NextCure  Inc

NASDAQ: NXTC
$1.43
+$0.03 (+2.1%)
Closing Price on September 19, 2024

NXTC Chart and Intraday Price

NXTC Company Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD, US
Fiscal Year End December
Latest Quarter 2023-12-31
Market Cap 60.27M USD
Shares Outstanding 27,903,000
NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other diseases related to the immune system by restoring normal immune function. The company is headquartered in Beltsville, Maryland.

NXTC Articles

Top Analyst Upgrades and Downgrades: Autodesk, Costco, Interactive Brokers, SBA Communications, Western Digital, Zscaler and More
Friday's top analyst upgrades and downgrades included Autodesk, Costco, Gap, Interactive Brokers, SBA Communications, Smith & Wesson, Western Digital and Zscaler.
Lee Jackson
Published:

Why Investors Are Pumping the Brakes on NextCure's Cancer Treatment
NextCure updated clinical results from its early stage cancer study at the Society for Immunotherapy of Cancer annual meeting. As a result, NextCure shares were crushed on Monday.
Chris Lange
Published:

Is NextCure the Next Big Cancer Biotech Every Investor Missed?
NextCure appears to be one of those companies that has flown under the radar of the investing community since its initial public offering in 2019.
Jon C. Ogg
Published:
Last Updated: